U.S. markets open in 5 hours 24 minutes

Intra-Cellular Therapies, Inc. (ITCI)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
35.03+1.60 (+4.79%)
At close: 4:00PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 5/8/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.32
52-Week Change 370.30%
S&P500 52-Week Change 344.45%
52 Week High 340.01
52 Week Low 317.26
50-Day Moving Average 332.38
200-Day Moving Average 331.24

Share Statistics

Avg Vol (3 month) 3550.39k
Avg Vol (10 day) 3601.27k
Shares Outstanding 581.2M
Implied Shares Outstanding 6N/A
Float 73.73M
% Held by Insiders 14.92%
% Held by Institutions 191.75%
Shares Short (Apr 14, 2021) 46.24M
Short Ratio (Apr 14, 2021) 413.39
Short % of Float (Apr 14, 2021) 410.29%
Short % of Shares Outstanding (Apr 14, 2021) 47.69%
Shares Short (prior month Mar 14, 2021) 46.34M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Dec 30, 2020


Profit Margin 0.00%
Operating Margin (ttm)-1,013.58%

Management Effectiveness

Return on Assets (ttm)-29.84%
Return on Equity (ttm)-53.30%

Income Statement

Revenue (ttm)22.81M
Revenue Per Share (ttm)0.32
Quarterly Revenue Growth (yoy)20,447.20%
Gross Profit (ttm)-44.86M
EBITDA -230.7M
Net Income Avi to Common (ttm)-227.01M
Diluted EPS (ttm)-3.23
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)657.45M
Total Cash Per Share (mrq)8.12
Total Debt (mrq)29.14M
Total Debt/Equity (mrq)4.44
Current Ratio (mrq)18.75
Book Value Per Share (mrq)8.16

Cash Flow Statement

Operating Cash Flow (ttm)-230.07M
Levered Free Cash Flow (ttm)-148.79M